Estrogen Receptor Analysis in Chronic Lymphocytic Leukemia
Overview
Authors
Affiliations
Estrogen receptor (ER) determinations were performed on cytosol preparations of Ficoll-Hypaque density separated mononuclear cells from 11 patients with chronic lymphocytic leukemia (CLL). The presence of ER was noted in 8 of 11 specimens (73%). ER ranged from 431 fmole/mg to 4.3 fmole/mg cytosol protein. Two types of receptor subunits were observed at the 8S and 4S region of the sucrose gradient. In addition, 1 of 3 Epstein-Barr virus (EBV) transformed B-lymphoblastoid cell lines from healthy donors had a measurable amount of ER. Patient R.L., who was refractory to standard chemotherapy and radiation and was ER positive, experienced a minor response to Tamoxifen therapy, with subsequent loss of ER. The demonstration of ER in CLL suggests that this malignancy may have a hormone-dependent subpopulation of cells.
Zhao J, Yu Y, Liu C, Liu R, Sun M, Zhuang J J Cancer. 2025; 16(3):888-897.
PMID: 39781360 PMC: 11705057. DOI: 10.7150/jca.100610.
Phytoestrogen-derived multifunctional ligands for targeted therapy of breast cancer.
Zhang Y, Pan H, Yu C, Liu R, Xing B, Jia B Asian J Pharm Sci. 2023; 18(4):100827.
PMID: 37588993 PMC: 10425851. DOI: 10.1016/j.ajps.2023.100827.
Allain E, Venzl K, Caron P, Turcotte V, Simonyan D, Gruber M Ann Hematol. 2018; 97(9):1649-1661.
PMID: 29781039 PMC: 6097785. DOI: 10.1007/s00277-018-3356-z.
An Integrative Computational Approach to Evaluate Genetic Markers for Chronic Lymphocytic Leukemia.
Zheng Y, Li X, Manor L, Cao H, Chen Q J Comput Biol. 2017; 24(9):942-952.
PMID: 28570130 PMC: 11753456. DOI: 10.1089/cmb.2017.0041.
Second neoplasms in patients with chronic lymphocytic leukemia.
Wiernik P Curr Treat Options Oncol. 2004; 5(3):215-23.
PMID: 15115650 DOI: 10.1007/s11864-004-0013-7.